The finding that an agonist of Nrf2 downregulated the expression of COX-2 was reported in a previous study, where it occurred through inhibition of nuclear factor kappaB (NF-kappaB) activation in vivo and in vitro of colitis (Lee et al., 2007). Here, PTGS2 is linked to colitis.